News & Updates

Sarcopoenia is a strong and independent predictor of mortality risk in cirrhotic patients, reveals a recent meta-analysis.

The risk of metabolic dysfunction-associated fatty liver disease (MAFLD) seems to be tied to prolonged exposure to ambient air pollutants, such as nitrogen dioxide and particulate matter with aerodynamic diameters of ≤1, ≤2.5, and ≤10 µm, a recent study reports.

In patients undergoing hepatectomy, an intervention with enteral ecoimmunonutrition (EEIN) support appears to protect liver function, reduce serum endotoxin levels and inflammatory factors, improve immune function, and promote the recovery of postoperative gastrointestinal function, according to a recent study. These findings prove that EEIN support is viable for clinical application.

At a population level, intrahepatic lipid (IHL) content seems to be a significant and independent predictor of soluble E-selectin (sE-selectin) levels, a recent study suggests.

Cirrhotic patients with acute decompensation (AD) are at heightened risk of de novo infection during hospitalization, specifically in the presence of overt hepatic encephalopathy, a study has found.

There is no causal relationship between genetic predisposition to nonalcoholic fatty liver disease (NAFLD) and increased risk of developing severe COVID-19, according to a Mendelian randomization study.